Sales Volume Growth (YoY)
10%
+10% YoY
Total sales volumes increased 10% year-on-year in Q3, driven by market share gains.
ORIENTALAROMATICS
Other
10 Feb 2026
Oriental Aromatics Limited — Q3 FY26
Oriental Aromatics reported Q3 FY26 revenue of ₹252 cr (+13% YoY), but EBITDA margin contracted sharply to 5.26% (down ~559 bps YoY) and PAT swung to a loss of ₹1.92 cr.
✓ Verified against BSE filing
2-Min Summary
Oriental Aromatics reported Q3 FY26 revenue of ₹252 cr (+13% YoY), but EBITDA margin contracted sharply to 5.26% (down ~559 bps YoY) and PAT swung to a loss of ₹1.92 cr. Volume growth remained healthy (sales +10% YoY), driven by market share gains in a soft pricing environment. However, margin compression persisted due to pricing pressure in aroma ingredients, unfavorable seasonal mix (post-festive camper slowdown), and the drag from Mahad's greenfield ramp-up (still at 30-35% utilization). Management guided for 8-10% full-year revenue growth and expects Mahad to reach breakeven in 2-3 quarters as commercial shipments ramp up. The recent US-India trade deal (tariff reduction to 18%) is seen as a positive catalyst for North American demand. Key risk: if pricing recovery is delayed or Mahad stabilization takes longer than expected, margins could remain under pressure.
Key Numbers
Production Growth (YoY)
3%
+3% YoY
Total production grew 3% YoY in Q3, reflecting steady operations.
Mahad Capacity Utilization
30-35%
N/A
Mahad plant is running at 30-35% capacity, still in early ramp-up phase.
Net Debt to Equity
0.65x
N/A
Balance sheet remains healthy with net debt-to-equity at 0.65x as of Dec 2025.
Management Guidance
Full-year revenue growth of 8-10%
Management expects FY26 revenue growth of 8-10% YoY, driven by volume gains and market share expansion.
revenueMahad to reach breakeven in 2-3 quarters
Mahad plant is expected to achieve breakeven within the next 2-3 quarters as commercial shipments ramp up and utilization improves.
growthUS tariff reduction to boost North American sales
The US-India trade deal reducing tariffs to 18% is expected to revive North American demand and support volume growth.
growthKey Risks
Pricing recovery may be delayed
Aroma ingredient pricing remains under pressure due to a buyer's market and Chinese competition; recovery timing is uncertain.
high · management_commentaryMahad ramp-up slower than expected
Mahad plant is still at 30-35% utilization and has taken longer to stabilize, with management citing geopolitical delays and longer customer approval cycles.
high · analyst_questionFMCG camper strategy not yielding results
Analyst noted limited e-commerce presence and lack of innovation in camper products; management declined to discuss strategy, indicating potential underperformance.
medium · analyst_questionNotable Quotes
We are currently in a sales maximization mode. And if you look at the sales number and if you look at the production number for 9 months or for year on year, we are achieving our targets.
I think we have to put the tariffs to rest. We have to now look forward and we have to take the advantage of this situation and grow the business.
I am not going to discuss my FMCG sales strategy with you on the investor call.